| John Houston, Ph.D. | Former President and Chief Executive Officer | FY2025 | |
| Noah Berkowitz, M.D., Ph.D. | Chief Medical Officer | FY2025 | |
| Andrew Saik | Chief Financial Officer and Treasurer | FY2025 | |
| Angela Cacace, Ph.D. | Chief Scientific Officer | FY2025 | |
| Ian Taylor, Ph.D. | Former President of Research and Development | FY2025 |
5 executives
Named executives and their total pay come from the Summary Compensation Table of the latest proxy statement.